{
  "id": [
    "29899236"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "29899236"
  ],
  "pmcid": [
    "PMC6025560"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC6025560"
      ]
    }
  ],
  "doi": [
    "10.3390/cancers10060197"
  ],
  "title": [
    "Antiviral Drugs for EBV."
  ],
  "authorString": [
    "Pagano JS, Whitehurst CB, Andrei G."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Pagano JS"
          ],
          "firstName": [
            "Joseph S"
          ],
          "lastName": [
            "Pagano"
          ],
          "initials": [
            "JS"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. joseph_pagano@med.unc.edu."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Whitehurst CB"
          ],
          "firstName": [
            "Christopher B"
          ],
          "lastName": [
            "Whitehurst"
          ],
          "initials": [
            "CB"
          ],
          "authorId": [
            {
              "_": "0000-0003-4740-2317",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. cbwhiteh@med.unc.edu."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Andrei G"
          ],
          "firstName": [
            "Graciela"
          ],
          "lastName": [
            "Andrei"
          ],
          "initials": [
            "G"
          ],
          "authorId": [
            {
              "_": "0000-0003-2609-4896",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Microbiology and Immunology, University of Leuven, BE-3000 Leuven, Belgium. Graciela.Andrei@rega.kuleuven.be."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0003-4740-2317",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0003-2609-4896",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "recommended_reviews",
        "altmetrics",
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "6"
      ],
      "volume": [
        "10"
      ],
      "journalIssueId": [
        "2692326"
      ],
      "dateOfPublication": [
        "2018 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2018"
      ],
      "printPublicationDate": [
        "2018-06-01"
      ],
      "journal": [
        {
          "title": [
            "Cancers"
          ],
          "ISOAbbreviation": [
            "Cancers (Basel)"
          ],
          "medlineAbbreviation": [
            "Cancers (Basel)"
          ],
          "NLMid": [
            "101526829"
          ],
          "ISSN": [
            "2072-6694"
          ],
          "ESSN": [
            "2072-6694"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2018"
  ],
  "abstractText": [
    "Epstein⁻Barr virus (EBV) infects up to 95% of the adult human population, with primary infection typically occurring during childhood and usually asymptomatic. However, EBV can cause infectious mononucleosis in approximately 35⁻50% cases when infection occurs during adolescence and early adulthood. Epstein⁻Barr virus is also associated with several B-cell malignancies including Burkitt lymphoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disease. A number of antiviral drugs have proven to be effective inhibitors of EBV replication, yet have resulted in limited success clinically, and none of them has been approved for treatment of EBV infections."
  ],
  "affiliation": [
    "Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. joseph_pagano@med.unc.edu."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "discussion",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "P01 CA019014"
          ],
          "agency": [
            "NCI NIH HHS"
          ],
          "acronym": [
            "CA"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Ganciclovir",
        "Acyclovir",
        "Antiviral",
        "Maribavir",
        "Epstein–barr Virus"
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.3390/cancers10060197"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6025560"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6025560?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "6"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCreation": [
    "2018-06-15"
  ],
  "firstIndexDate": [
    "2018-06-15"
  ],
  "fullTextReceivedDate": [
    "2018-07-11"
  ],
  "dateOfRevision": [
    "2019-04-26"
  ],
  "electronicPublicationDate": [
    "2018-06-13"
  ],
  "firstPublicationDate": [
    "2018-06-13"
  ]
}